With the Mitigare® True Blue Savings Card, eligible patients can receive Generic Colchicine 0.6 mg Capsules or Mitigare® (Colchicine) 0.6 mg Capsules for as little as $0 for the first 30 days and refills for as little as $5.* Can be used on Generic Colchicine Capsules or Mitigare® Capsules.

Ready to start saving? See how it works.

Pay as little as

*For all eligible patients 18 years or older who are legal residents of the United States or Puerto Rico. First 30 days are as little as $0 and refills are as little as $5 for eligible patients. Maximum savings of $65 on the first fill and $50 on refills. Please see complete Terms and Conditions.

How It Works

Get a True Blue Savings Card

Option 1:
Visit your doctor and ask him/her to give you the Savings Card when he/she prescribes Mitigare® (Colchicine) 0.6 mg Capsules or Authorized Generic Colchicine 0.6 mg Capsules. Then, activate your card online.

Option 2:
Or, download your True Blue Savings Card online.

With the Mitigare® True Blue Savings Card, eligible patients can receive their first fill for as little as $0 per month up to a maximum value of $65. For refills, eligible patients can save on their out-of-pocket costs and pay as little as $5 per refill for their Mitigare® (Colchicine) 0.6 mg Capsules (or its Authorized Generic Colchicine 0.6 mg Capsules) prescription up to a maximum value of $50 per 30-day supply (up to a maximum of 60 capsules).

Dispenses for 60 day supply (up to a maximum of 120 capsules) and 90 day supply (up to a maximum of 180 capsules) are permissible within the terms of the Mitigare® True Blue Savings program, up to a total of a 12-month supply.

Find out if you are eligible for True Blue Savings now!

Option 3:
If you are uninsured, underinsured or are not eligible for the True Blue Savings Card, you may be able to access discounts for Authorized Generic Colchicine 0.6 mg Capsules or Mitigare® by using the Inside Rx pharmacy discount card. Inside Rx offers a discount option for eligible cash paying patients.

See if you are eligible and view average potential savings for Generic Colchicine Capsules or Mitigare® at InsideRx.com. The Inside Rx card is accepted at nearly 40,000 pharmacies nationwide. The card is not insurance, and there is no membership fee. View a list of participating pharmacies, eligibility and medication information, and other important terms and restrictions.

Important Safety Information for Mitigare® (colchicine) 0.6 mg capsules

  • Colchicine 0.6 mg capsules are contraindicated in patients with renal or hepatic impairment who are currently prescribed drugs that inhibit both P-gp and CYP3A4. Combining these dual inhibitors with colchicine in patients with renal or hepatic impairment has resulted in life-threatening or fatal colchicine toxicity. Patients with both renal and hepatic impairment should not be given Mitigare®.
  • Fatal overdoses have been reported with colchicine in adults and children. Keep Mitigare® out of the reach of children.
  • Blood dyscrasias such as myelosuppression, leukopenia, granulocytopenia, thrombocytopenia, and aplastic anemia have been reported with colchicine used in therapeutic doses.
  • Monitor for toxicity and if present consider temporary interruption or discontinuation of colchicine.
  • Drug interaction with dual P-gp and CYP3A4 inhibitors: Co-administration of colchicine with dual P-gp and CYP3A4 inhibitors has resulted in life-threatening interactions and death.
  • Neuromuscular toxicity and rhabdomyolysis may occur with chronic treatment with colchicine in therapeutic doses, especially in combination with other drugs known to cause this effect. Patients with impaired renal function and elderly patients (including those with normal renal and hepatic function) are at increased risk. Consider temporary interruption or discontinuation of Mitigare®.
  • The most commonly reported adverse reactions with colchicine are gastrointestinal symptoms, including diarrhea, nausea, vomiting, and abdominal pain.

Indication

Mitigare® is indicated for prophylaxis of gout flares in adults. The safety and effectiveness of Mitigare for acute treatment of gout flares during prophylaxis has not been studied.

Mitigare® is not an analgesic medication and should not be used to treat pain from other causes.

For Full Prescribing Information please CLICK HERE and for Medication Guide CLICK HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.

Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Manufactured by: West-Ward Columbus Inc., Columbus, OH 43228

Important Safety Information for Mitigare® (colchicine) 0.6 mg capsules

  • Colchicine 0.6 mg capsules are contraindicated in patients with renal or hepatic impairment who are currently prescribed drugs that inhibit both P-gp and CYP3A4. Combining these dual inhibitors with colchicine in patients with renal or hepatic impairment has resulted in life-threatening or fatal colchicine toxicity. Patients with both renal and hepatic impairment should not be given Mitigare®.
  • Fatal overdoses have been reported with colchicine in adults and children. Keep Mitigare® out of the reach of children.